UBS Group
PLSE icon

UBS Group’s Pulse Biosciences PLSE Stock Holding History

UBS Group’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$733K Sell
33,954
-41,955
-55% -$774K ﹤0.01% 5785
2025
Q4 		$1.04M Sell
75,909
-947
-1% -$14.8K ﹤0.01% 5533
2025
Q3 		$1.36M Buy
76,856
+26,739
+53% +$423K ﹤0.01% 5304
2025
Q2 		$756K Sell
50,117
-4,615
-8% -$76.6K ﹤0.01% 5679
2025
Q1 		$881K Buy
54,732
+27,194
+99% +$507K ﹤0.01% 5393
2024
Q4 		$479K Buy
27,538
+14,746
+115% +$260K ﹤0.01% 5876
2024
Q3 		$224K Buy
12,792
+7,222
+130% +$123K ﹤0.01% 5785
2024
Q2 		$62.3K Sell
5,570
-10,628
-66% -$100K ﹤0.01% 6518
2024
Q1 		$141K Sell
16,198
-2,463
-13% -$22.6K ﹤0.01% 6063
2023
Q4 		$228K Buy
18,661
+9,632
+107% +$66.7K ﹤0.01% 5705
2023
Q3 		$36.4K Sell
9,029
-353
-4% -$2.19K ﹤0.01% 6485
2023
Q2 		$67.5K Buy
+9,382
New +$59.9K ﹤0.01% 6292
2022
Q4 		– Sell
-100
Closed – – 11039
2022
Q3 		$0 Sell
100
-703
-88% -$1.14K ﹤0.01% 10785
2022
Q2 		$1K Buy
803
+480
+149% +$1.21K ﹤0.01% 9930
2022
Q1 		$2K Sell
323
-6,471
-95% -$53K ﹤0.01% 9657
2021
Q4 		$101K Buy
+6,794
New +$135K ﹤0.01% 6315
2021
Q2 		– Sell
-3,264
Closed -$77K – 9711
2021
Q1 		$77K Sell
3,264
-3,899
-54% -$117K ﹤0.01% 6164
2020
Q4 		$171K Sell
7,163
-1,272
-15% -$20.2K ﹤0.01% 5335
2020
Q3 		$99K Sell
8,435
-4,265
-34% -$45.9K ﹤0.01% 5190
2020
Q2 		$133K Sell
12,700
-2,589
-17% -$23.3K ﹤0.01% 5097
2020
Q1 		$109K Buy
15,289
+415
+3% +$4.31K ﹤0.01% 5221
2019
Q4 		$199K Buy
14,874
+1,583
+12% +$22.6K ﹤0.01% 5607
2019
Q3 		$205K Buy
13,291
+5,723
+76% +$74.3K ﹤0.01% 5234
2019
Q2 		$100K Sell
7,568
-2,861
-27% -$39K ﹤0.01% 5372
2019
Q1 		$183K Sell
10,429
-2,720
-21% -$42.7K ﹤0.01% 4653
2018
Q4 		$151K Sell
13,149
-4,565
-26% -$55.2K ﹤0.01% 5178
2018
Q3 		$251K Buy
17,714
+986
+6% +$14K ﹤0.01% 4894
2018
Q2 		$253K Buy
16,728
+7,914
+90% +$134K ﹤0.01% 4785
2018
Q1 		$119K Sell
8,814
-14
-0.2% -$266 ﹤0.01% 5113
2017
Q4 		$208K Sell
8,828
-3,598
-29% -$84.9K ﹤0.01% 4873
2017
Q3 		$231K Buy
12,426
+3,199
+35% +$72.7K ﹤0.01% 4753
2017
Q2 		$319K Sell
9,227
-16,559
-64% -$455K ﹤0.01% 4450
2017
Q1 		$526K Sell
25,786
-10,064
-28% -$137K ﹤0.01% 4000
2016
Q4 		$233K Buy
35,850
+4,511
+14% +$26.7K ﹤0.01% 4687
2016
Q3 		$197K Buy
31,339
+3,344
+12% +$17.1K ﹤0.01% 4558
2016
Q2 		$126K Buy
+27,995
New +$120K ﹤0.01% 4872

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

UBS Group's PLSE Position: Q1 2026 in Review

UBS Group reduced its Pulse Biosciences (PLSE) stake by 55% in Q1 2026, selling an estimated $774K and leaving 33,954 shares worth $733K. The position accounts for ﹤0.01% of the portfolio, ranked #5785.

UBS Group first reported a position in PLSE in Q2 2016 and has held it in 36 quarters since. The position peaked at $1.36M in Q3 2025. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • UBS Group held 33,954 shares of Pulse Biosciences worth $733K as of Q1 2026.
  • UBS Group sold 41,955 Pulse Biosciences shares in Q1 2026, an estimated $774K.
  • Pulse Biosciences made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5785 holding.
  • UBS Group first reported a position in Pulse Biosciences in Q2 2016 and has held it in 36 quarters since.
  • UBS Group's Pulse Biosciences position peaked at $1.36M in Q3 2025.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.